Leiden University Medical Center To Use FlexGen's FlexArrayer | GenomeWeb
NEW YORK (GenomeWeb News) - Leiden University Medical Center said yesterday that it has acquired a FlexArrayer from FlexGen for in-house synthesis of oligonucleotide microarrays.
FlexGen is a LUMC spinoff company.
Johan den Dunnen, head of the Leiden Genome Technology Center, said in a statement that the center will use the FlexArrayer for “well established types of genetic analyses but [we] also intend to work on the development of new applications.”

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.